New Orleans, Louisiana
Albany, New York
Mt. Laurel, New Jersey
Morristown, New Jersey
Seattle, WA (Ballard)
Highland Park, IL
Falls Church, Virginia
Lock Haven, Pennsylvania
Location: Chicago, Illinois
Internal Number: 317933
The Department of Pediatrics at Rush University Medical Center is recruiting two candidates for a F.A.S.T Fellowship in Clinical Trials for Innovative Therapeutics in Angelman syndrome and other Neurogenetic Disorders to join the Department of Pediatrics, Division of Pediatric Neurology for a one-year fellowship in translational neuroscience. We welcome both domestic and international candidates to apply. This is a unique opportunity for qualified individuals to further develop their translational and clinical research training at a leading academic medical center, conducting this work with mentorship in cutting-edge research using mechanism-targeted treatment for Angelman syndrome and other rare monogenic NDDs.
This one-year fellowship opportunity is for physicians to be mentored in the translational neuroscience program headed by Elizabeth Berry-Kravis, MD, PhD. As the leading investigator in multiple NIH-funded research programs and industry-and foundation-sponsored clinical trials, Dr. Berry-Kravis has established Rush University Medical Center as an international destination for rare disease treatment and research in the area of pediatric neurodevelopmental and neurogenetic conditions. During the one-year fellowship, the F.A.S.T. fellow will learn about clinical trial design, including novel clinical trials for rare genetic pediatric NDDs including N-of-1 trials, development of specialized programs for clinical management of these conditions with accommodation of experimental treatments, and new outcome measure and biomarker development for these populations. The fellowship will include time in clinic, however the majority of time will be spent working and training on translational and clinical research.
The successful candidate will have recently completed fellowship in Child Neurology (preferred), Child Psychiatry or Developmental Behavioral Pediatrics, and will have an interest in starting a career in translational neuroscience for neurodevelopmental disorders.
Interested candidates, please send your CV and cover letter to:
Recruiter, Department of Provider & Faculty RecruitmentFaculty_Recruitment@Rush.edu
The Foundation for Angelman Syndrome Therapeutics (FAST), is the primary patient advocacy organization devoted to a cure for Angelman Syndrome. As the largest non-governmental funder of AS research, FAST sets the agenda for the entire drug development ecosystem for this rare disease. Our goal is to bring transformative treatments into current medical practice as quickly and safely as possible, in order to ensure that individuals living with Angelman syndrome are able to reach their full potential and quality of life as soon as humanly possible. This fellowship is funded as part of the new RUSH-F.A.S.T. Center for clinical trials and translational research efforts underway for rare neurodevelopmental disorders.
Rush University System for Health is an academic health system whose mission is to improve the health of the individuals and the diverse communities it serves through the integration of outstanding patient care, education, research and community partnerships. Rush includes Rush University Medical Center, Rush University, Rush Copley Medical Center and Rush Oak Park Hospital, as well as numerous outpatient care facilities. Rush University, with more than 2,500 students, is a health sciences university that comprises Rush Medical College, the College of Nursing, the College of Health Sciences and the Graduate College. Rush University Medical Center is an elite medical community recognized for excellence in patient care, medical discovery and clinical expertise. Our continued pursuits have earned Rush University Medical Center the distinction of being on U.S. News & World Report's Best Hospitals Honor Roll for 2022-2023. This places the Medical Center amongst the top 20 of the more than 4,500 hospitals evaluated. U.S. News & World Report has also recognized ten Rush programs amongst the nation's best, including top ten national rankings for neurology and neurosurgery and orthopedics. These accolades, along with many others that include a decade of Magnet(r) designation, reflect the collective efforts and commitment to excellence demonstrated by our physicians, advanced practitioners, nurses and medical staff.
Rush University Medical Center has received Vizient's Quality Leadership Award, ranking first among 99 academic medical centers across the country. All three Rush University System for Health hospitals have earned the LGBTQ Healthcare Equality Leader designation in the Healthcare Equality Index.
Rush is an equal opportunity / Affirmative Action employer